Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hypersensitivity Reaction

  Free Subscription


07.01.2019

1 Allergy
2 Allergy Asthma Proc
7 Ann Allergy Asthma Immunol
1 Br J Dermatol
2 Eur Respir J
2 Int Arch Allergy Immunol
1 J Allergy Clin Immunol
3 J Am Acad Dermatol
3 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. NAKAHARA T, Fujita H, Arima K, Taguchi Y, et al
    Treatment satisfaction in atopic dermatitis relates to patient-reported severity: a cross-sectional study.
    Allergy. 2018 Dec 28. doi: 10.1111/all.13712.
    PubMed     Text format    


    Allergy Asthma Proc

  2. ZHANG X, Zheng J, Zhang L, Liu Y, et al
    Systemic inflammation mediates the detrimental effects of obesity on asthma control.
    Allergy Asthma Proc. 2018;39:43-50.
    PubMed     Text format     Abstract available

  3. MELTZER EO, Berger WE
    A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
    Allergy Asthma Proc. 2018;39:14-26.
    PubMed     Text format     Abstract available


    Ann Allergy Asthma Immunol

  4. PETRONI D, Spergel JM
    Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy.
    Ann Allergy Asthma Immunol. 2018;120:237-240.
    PubMed     Text format    

  5. WANG D, Wang Y, Liang H, David JE, et al
    Race and ethnicity have significant influence on fractional exhaled nitric oxide.
    Ann Allergy Asthma Immunol. 2018;120:272-277.
    PubMed     Text format     Abstract available

  6. SAVARY KW, Miller RL, Arteaga-Solis E, Hoepner L, et al
    Infant rhinitis and watery eyes predict school-age exercise-induced wheeze, emergency department visits and respiratory-related hospitalizations.
    Ann Allergy Asthma Immunol. 2018;120:278-284.
    PubMed     Text format     Abstract available

  7. KIM A, Lim G, Oh I, Kim Y, et al
    Perinatal factors and the development of childhood asthma.
    Ann Allergy Asthma Immunol. 2018;120:292-299.
    PubMed     Text format     Abstract available

  8. NETTIS E, Cegolon L, Di Leo E, Canonica WG, et al
    Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
    Ann Allergy Asthma Immunol. 2018;120:318-323.
    PubMed     Text format     Abstract available

  9. ANIBARRO B, Seoane FJ
    Ethanol-induced urticaria caused by sensitization to acetic acid.
    Ann Allergy Asthma Immunol. 2018;120:337-338.
    PubMed     Text format    

  10. CHUNG J, Simpson EL
    The Socioeconomics of Atopic Dermatitis.
    Ann Allergy Asthma Immunol. 2018 Dec 28. pii: S1081-1206(18)31568.
    PubMed     Text format    


    Br J Dermatol

  11. BAKKER DS, Ariens LFM, van Luijk C, van der Schaft J, et al
    Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis.
    Br J Dermatol. 2018 Dec 30. doi: 10.1111/bjd.17538.
    PubMed     Text format     Abstract available


    Eur Respir J

  12. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    

  13. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    Int Arch Allergy Immunol

  14. MORI F, Liccioli G, Piccorossi A, Sarti L, et al
    The Diagnosis of Ceftriaxone Hypersensitivity in a Paediatric Population.
    Int Arch Allergy Immunol. 2019 Jan 3:1-5. doi: 10.1159/000495302.
    PubMed     Text format     Abstract available

  15. GANI F, Lombardi C, Bonizzoni G, Rolla G, et al
    The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study.
    Int Arch Allergy Immunol. 2019 Jan 3:1-5. doi: 10.1159/000495305.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  16. ZIMMERMANN P, Messina N, Mohn WW, Finlay BB, et al
    Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review.
    J Allergy Clin Immunol. 2018 Dec 29. pii: S0091-6749(18)31431.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  17. HOSKING AM, Juhasz M, Mesinkovska NA
    Topical Janus kinase inhibitors: A review of applications in dermatology.
    J Am Acad Dermatol. 2018;79:535-544.
    PubMed     Text format     Abstract available

  18. VASHI NA, Patzelt N, Wirya S, Maymone MBC, et al
    Dermatoses caused by cultural practices: Cosmetic cultural practices.
    J Am Acad Dermatol. 2018;79:19-30.
    PubMed     Text format     Abstract available

  19. STEINKE S, Zeidler C, Riepe C, Bruland P, et al
    Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.
    J Am Acad Dermatol. 2018;79:457-463.
    PubMed     Text format     Abstract available


    N Engl J Med

  20. KUHN DM
    Aspirin-Exacerbated Respiratory Disease.
    N Engl J Med. 2018;379:2281.
    PubMed     Text format    

  21. RUSZNAK RM, Peebles S
    Aspirin-Exacerbated Respiratory Disease.
    N Engl J Med. 2018;379:2280-2281.
    PubMed     Text format    

  22. WHITE AA, Stevenson DD
    Aspirin-Exacerbated Respiratory Disease.
    N Engl J Med. 2018;379:2281-2282.
    PubMed     Text format    


    PLoS One

  23. VELASCO-TIRADO V, Alonso-Sardon M, Cosano-Quero A, Romero-Alegria A, et al
    Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).
    PLoS One. 2018;13:e0198582.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: